Trial Profile
Prescription Opioid Abuse Among Pain Patients: Predictors of Relapse
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Jun 2018
Price :
$35
*
At a glance
- Drugs Buprenorphine/naloxone (Primary)
- Indications Opioid-related disorders; Pain
- Focus Therapeutic Use
- Acronyms PAIN
- 04 Nov 2013 New trial record